Zobrazeno 1 - 10
of 133
pro vyhledávání: '"Tacjana Pressler"'
Autor:
Bibi Uhre Nielsen, Christine Råberg Mikkelsen, Peter Sandor Oturai, Rikke Krogh-Madsen, Terese Lea Katzenstein, Christian Ritz, Tacjana Pressler, Thomas Peter Almdal, Inger Hee Mabuza Mathiesen, Daniel Faurholt-Jepsen
Publikováno v:
Frontiers in Endocrinology, Vol 15 (2024)
ObjectiveWe hypothesized that the insulin-sensitizing adipokine adiponectin (ADP) is upregulated in cystic fibrosis (CF) related diabetes (CFRD) and underweight adults with CF. We aimed to assess correlations between glucose metabolism, body composit
Externí odkaz:
https://doaj.org/article/1148db1751e04df3892f3667b46c209c
Autor:
Rikke Møller, Bibi Uhre Nielsen, Elio Rossi, Mads Lausen, Marianne Skov, Tacjana Pressler, Sisse Rye Ostrowski, Helle Krogh Johansen
Publikováno v:
ERJ Open Research, Vol 10, Iss 4 (2024)
Objectives Lung disease progression in people with cystic fibrosis (pwCF) varies from one individual to another. Different immunological characteristics have been suggested to explain this variation, and we hypothesised that lung capacity may be asso
Externí odkaz:
https://doaj.org/article/4c893a60a3db4c2381593f3e4302d498
Autor:
Rikke M. Sandvik, Marika N. Schmidt, Christian M. Voldby, Frederik F. Buchvald, Hanne V. Olesen, Jørgen Olsen, Maja V. Kragh, Sune L.M. Rubak, Tacjana Pressler, Paul D. Robinson, Per M. Gustafsson, Marianne Skov, Kim G. Nielsen
Publikováno v:
ERJ Open Research, Vol 9, Iss 5 (2023)
Background Cystic fibrosis (CF) lung disease starts in infancy and can be assessed for structural lung abnormalities using computed tomography or magnetic resonance scans, or for lung function impairment using multiple breath washout (MBW). However,
Externí odkaz:
https://doaj.org/article/e73f128224c047ff8935ae28028fb742
Autor:
Bibi Uhre Nielsen, Inger Hee Mabuza Mathiesen, Rikke Møller, Rikke Krogh-Madsen, Terese Lea Katzenstein, Tacjana Pressler, James A. M. Shaw, Christian Ritz, Michael R. Rickels, Darko Stefanovski, Thomas Peter Almdal, Daniel Faurholt-Jepsen
Publikováno v:
Frontiers in Endocrinology, Vol 14 (2023)
AimsThe purpose of the study was to further elucidate the pathophysiology of cystic fibrosis (CF)-related diabetes (CFRD) and potential drivers of hypoglycaemia. Hence, we aimed to describe and compare beta cell function (insulin and proinsulin) and
Externí odkaz:
https://doaj.org/article/88132567683d426abc643eb60765c95a
Autor:
Renan Marrichi Mauch, Peter Østrup Jensen, Tavs Qvist, Mette Kolpen, Claus Moser, Tacjana Pressler, Marcos Tadeu Nolasco da Silva, Niels Høiby, The Copenhagen Study Group on Mycobacterial Infections in Cystic Fibrosis, Daniel Faurholt-Jepsen, Marco Gelpi, Neval Ete Wareham, Terese Katzenstein
Publikováno v:
Frontiers in Cellular and Infection Microbiology, Vol 12 (2022)
BackgroundWe aimed to characterise the adaptive immune response to Mycobacterium abscessus complex (MABSC) and its cross-reactivity with Mycobacterium avium complex (MAC) and Mycobacterium bovis (Bacille Calmette-Guérin, BCG) in cystic fibrosis (CF)
Externí odkaz:
https://doaj.org/article/a9cd74cc56be43359254e189c9b7cf1e
Autor:
Bibi Uhre Nielsen, Daniel Faurholt-Jepsen, Peter Sandor Oturai, Tavs Qvist, Rikke Krogh-Madsen, Terese Lea Katzenstein, James Shaw, Christian Ritz, Tacjana Pressler, Thomas Peter Almdal, Inger Hee Mabuza Mathiesen
Publikováno v:
Clinical Medicine Insights: Endocrinology and Diabetes, Vol 14 (2021)
Background: A frequent comorbidity in cystic fibrosis (CF) is CF related diabetes (CFRD) caused by a gradual decline in insulin secretion. The reduction in the anabolic hormone, insulin, might explain the weight loss that precedes onset of CFRD. We i
Externí odkaz:
https://doaj.org/article/7976cdda55fa499b9029168e96d5175b
Autor:
Jennifer A Bartell, David R Cameron, Biljana Mojsoska, Janus Anders Juul Haagensen, Tacjana Pressler, Lea M Sommer, Kim Lewis, Søren Molin, Helle Krogh Johansen
Publikováno v:
PLoS Pathogens, Vol 16, Iss 12, p e1009112 (2020)
Despite intensive antibiotic treatment, Pseudomonas aeruginosa often persists in the airways of cystic fibrosis (CF) patients for decades, and can do so without antibiotic resistance development. Using high-throughput screening assays of bacterial su
Externí odkaz:
https://doaj.org/article/fdc46894290d4cdfaca1093c8358aed2
Autor:
Mette F. Olsen, Maria S. Kjøller-Svarre, Grith Møller, Terese L. Katzenstein, Bibi U. Nielsen, Tacjana Pressler, Jack I. Lewis, Inger H. Mathiesen, Christian Mølgaard, Daniel Faurholt-Jepsen
Publikováno v:
Nutrients, Vol 14, Iss 7, p 1330 (2022)
Most people with cystic fibrosis (pwCF) develop pancreatic insufficiency and are treated with pancreatic enzyme replacement therapy (PERT). We aimed to describe the use of PERT and assess the correlates of PERT dose in adult pwCF. In a cross-sectiona
Externí odkaz:
https://doaj.org/article/f2a58149005b48308ff3e440ce59d565
Autor:
Silke van Koningsbruggen-Rietschel, Jane C. Davies, Tacjana Pressler, Rainald Fischer, Gordon MacGregor, Scott H. Donaldson, Knut Smerud, Nils Meland, Jann Mortensen, Marie Ø. Fosbøl, Damian G. Downey, Astrid H. Myrset, Hugo Flaten, Philip D. Rye, The following investigators and their teams (in alphabetical order) conducted this study., Mary Carroll, Jane Davies, Carsten Schwarz, Nico Derichs, Damian Downey, Olaf Eickmeier, Pal Leyell Finstad, Marie Øbro Fossbøl, Marita Gilljam, Lena Hjelte, Alan Knox, Susanne Nährig, Joachim Riethmüller, Felix C. Ringshausen, AS AlgiPharma, Laura Gow, Joy Conway, William Bennett
Publikováno v:
ERJ Open Research, Vol 6, Iss 4 (2020)
Background OligoG is a low molecular-weight alginate oligosaccharide that improves the viscoelastic properties of cystic fibrosis (CF) mucus and disrupts biofilms, thereby potentiating the activity of antimicrobial agents. The efficacy of inhaled Oli
Externí odkaz:
https://doaj.org/article/bf6a51f4c4a3405ebe8677a3a47a674d
Autor:
Malene Risum, Rasmus Krøger Hare, Jan Berg Gertsen, Lise Kristensen, Helle Krogh Johansen, Jannik Helweg-Larsen, Nissrine Abou-Chakra, Tacjana Pressler, Marianne Skov, Søren Jensen-Fangel, Maiken Cavling Arendrup
Publikováno v:
Frontiers in Microbiology, Vol 11 (2020)
Azole-resistant (azole-R) Aspergillus is an increasing challenge worldwide. Patients with cystic fibrosis (CF) are at risk of Aspergillus colonization and disease due to a favorable lung environment for microorganisms. We performed a nationwide study
Externí odkaz:
https://doaj.org/article/a55da7b8f0004dedb2a0833a19357ce2